All lobbying filings

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS filed a Q3 report for ORCHARD THERAPEUTICS NORTH AMERICA on October 19, 2026, reporting $30,000 in lobbying income.

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

All filings by CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS · Everything ORCHARD THERAPEUTICS NORTH AMERICA has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Metachromatic Leukodystrophy included on Recommended Uniform Screening Panel (RUSP) Metachromatic Leukodystrophy treatment

Budget/Appropriations

Funding for implementation of Recommended Uniform Screening Panel (RUSP)

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.